Carcinoembryonic antigen in patients with urologic cancers
β Scribed by Guinan, P. ;Ablin, R.J. ;Barakat, H. ;John, T. ;Sadoughi, N. ;Bush, I.M.
- Publisher
- Springer
- Year
- 1973
- Tongue
- English
- Weight
- 348 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Serum prostateβspecific antigen (PA), a new tumor marker of prostate cancer, was evaluated with an enzyme immunoassay (EIA) in various urologic cancer patients and benign prostatic diseases in Japanese. Sera of prostate cancer patients before treatment (n = 27) revealed a range of PA co
Carcinoembryonic antigen (CEA) levels were determined in 742 postoperative patients with breast cancer. Within this group the percentage of elevated (24.0 ng/ml) assays increased with UICC clinical stage and was 14.8% (12/81), 23.7% (27/114), 73.1% (190/260) and 20.0% (49/245) for stages I, 11, 111,